Canton Strategic Holdings CNTN
NASDAQ CNTN
$2.28 +0.03 (+1.33%)
As of: Sep 4, 2026 · 3:59 PM EDT

Canton Strategic Holdings (CNTN) Current Assets (2020 - 2026)

Canton Strategic Holdings' (CNTN) quarterly Current Assets came in at $43.1 million in Q1 2026, up 2493.48% YoY from $1.7 million in Q1 2025, and up 147.81% on a QoQ basis from $17.4 million in Q4 2025.

Analysis

Canton Strategic Holdings (CNTN) Current Assets (2020 - 2026) Analysis & Trends

Canton Strategic Holdings (CNTN) has 7 years of Current Assets data on file, last reported at $43.1 million in Q1 2026.

  • Quarterly Current Assets rose 2493.48% year-over-year to $43.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $43.1 million (up 2493.48% YoY) and the FY2025 annual result came in at $17.4 million, up 367.16% from the prior year.
  • Current Assets climbed to $43.1 million in Q1 2026, from $17.4 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $43.1 million in Q1 2026 to a low of $1.7 million in Q1 2025.
  • A 5-year average of $9.4 million and a median of $7.7 million in 2025 frame the typical range for Current Assets.
  • Annual changes were most pronounced in 2025 — Current Assets plunged 81.31% — and 2026, when it jumped 2493.48%.
  • Tracing CNTN's Current Assets over 5 years: stood at $6.7 million in 2022, then surged by 63.66% to $10.9 million in 2023, then plunged by 66.0% to $3.7 million in 2024, then jumped by 367.16% to $17.4 million in 2025, then jumped by 147.81% to $43.1 million in 2026.
  • The last three Current Assets figures came in at $43.1 million (Q1 2026), $17.4 million (Q4 2025), and $7.7 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 12.54 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 18.45 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 8.07 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 5.82 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 4.03 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 7.22 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 4.62 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 1.76 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 1.63 Bn
10 Canton Strategic Holdings 493.37 Mn 493.37 Mn - 41.22 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 41.22 Mn
Mar 31, 2026 43.09 Mn
Dec 31, 2025 17.39 Mn
Sep 30, 2025 7.70 Mn
Jun 30, 2025 2.53 Mn
Mar 31, 2025 1.66 Mn
Dec 31, 2024 3.72 Mn
Sep 30, 2024 5.25 Mn
Jun 30, 2024 8.26 Mn
Mar 31, 2024 8.89 Mn
Dec 31, 2023 10.95 Mn
Sep 30, 2023 3.17 Mn
Jun 30, 2023 4.60 Mn
Mar 31, 2023 4.72 Mn
Dec 31, 2022 6.69 Mn
Sep 30, 2022 8.02 Mn
Jun 30, 2022 10.25 Mn
Mar 31, 2022 12.09 Mn
Dec 31, 2021 621,677.00
Dec 31, 2020 294,798.00